Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma

Author:

Motzer Robert J.1ORCID,McDermott David F.2,Escudier Bernard3,Burotto Mauricio4,Choueiri Toni K.5ORCID,Hammers Hans J.6,Barthélémy Philippe7,Plimack Elizabeth R.8,Porta Camillo9,George Saby10,Powles Thomas11,Donskov Frede12,Gurney Howard13,Kollmannsberger Christian K.14,Grimm Marc‐Oliver15,Barrios Carlos16,Tomita Yoshihiko17,Castellano Daniel18,Grünwald Viktor19,Rini Brian I.20,McHenry M. Brent21,Lee Chung‐Wei22,McCarthy Jennifer23,Ejzykowicz Flavia24,Tannir Nizar M.25

Affiliation:

1. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

2. Division of Medical Oncology Beth Israel Deaconess Medical Center, Dana‐Farber/Harvard Cancer Center Boston Massachusetts

3. Department of Medical Oncology Gustave Roussy Villejuif France

4. Bradford Hill Clinical Research Center Santiago Chile

5. Department of Medical Oncology Lank Center for Genitourinary OncologyDana‐Farber Cancer InstituteBrigham and Women's Hospital, and Harvard Medical School Boston Massachusetts

6. Department of Medical Oncology University of Texas Southwestern Kidney Cancer Program Dallas Texas

7. Medical Oncology Strasbourg European Cancer Institute Strasbourg France

8. Department of Hematology and Oncology Fox Chase Cancer Center Philadelphia Pennsylvania

9. Department of Internal Medicine University of Pavia Pavia Italy

10. Department of Medicine Roswell Park Cancer Institute Buffalo New York

11. Department of Genitourinary Oncology Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Center, Queen Mary University of London, Royal Free National Health Service Trust London United Kingdom

12. Department of Oncology Aarhus University Hospital Aarhus Denmark

13. Department of Medical Oncology Westmead Hospital and Macquarie University Sydney New South Wales Australia

14. Department of Medicine British Columbia Cancer Agency Vancouver British Columbia Canada

15. Department of Urology Jena University Hospital Jena Germany

16. Oncology Research Unit Saint Luke HospitalPontifical Catholic University of Rio Grande do Sul Porto Alegre Brazil

17. Departments of Urology and Molecular Oncology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan

18. Medical Oncology Department October 12th University HospitalCancer Network Biomedical Research Center Madrid Spain

19. Interdisciplinary Genitourinary Oncology West German Cancer Center Clinic for Internal Medicine and Clinic for Urology, University Hospital Essen Essen Germany

20. Division of Hematology and Oncology Vanderbilt University Medical Center Nashville Tennessee

21. Department of Biostatistics Bristol Myers Squibb Princeton New Jersey

22. Department of Clinical Trials Bristol Myers Squibb Princeton New Jersey

23. Department of Clinical Scientists Bristol Myers Squibb Princeton New Jersey

24. Department of Health Economics and Outcomes Research Bristol Myers Squibb Princeton New Jersey

25. Department of Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

Funder

Bristol-Myers Squibb

National Institutes of Health

Memorial Sloan-Kettering Cancer Center

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3